Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Digital Rectal Examination (Rectal Examination with a Finger) Remains an Important Diagnostic Tool for Prostate Cancer

Digital Rectal Examination (Rectal Examination with a Finger) Remains an Important Diagnostic Tool for Prostate Cancer

In the modern era of advanced imaging and genetic testing, digital rectal examination (also known as rectal palpation or examination of the rectum with a finger), for prostate cancer , remains an important and clinically meaningful diagnostic and prognostic (predictive of disease course) test, as shown by a new observational study .

The role of digital rectal examination, a "historical" method of staging prostate cancer, had been debated in recent years. This was because of the development of other prognostic tools such as the 4K score, Decipher and magnetic resonance imaging . Furthermore, no one had previously investigated the usefulness of digital rectal examination in a more modern setting.

For a long time, digital rectal examination, a prostate-specific antigen (PSA) value and a Gleason score together served as the main tools for predicting disease course in prostate cancer and influencing treatment decisions.

This new observational, retrospective study shows that clinical staging through digital rectal examination is significantly prognostic (predictive of disease course) for overall survival among men with high-risk early-stage prostate cancer in a contemporary patient cohort in a US database (treated between 2004-2010).

In brief, the old tool still works in a contemporary setting.

The study was published online in Journal of the National Comprehensive Cancer Network in the journal's July issue.

All urologists already perform a digital rectal examination when examining an adult male patient for the first time. However, in patients with biopsy -proven prostate cancer, being able to palpate (feel) a tumor with your finger provides an inexpensive prognostic tool. Nevertheless, digital rectal examination is not "near the top" of the list of such tools, which includes PSA, Gleason score, magnetic resonance and genetic testing.

The study authors note that tumor size (T stage) detected by digital rectal examination is part of the risk classification system for prostate cancer patients.

However, anecdotally, doctors are moving away from an inexpensive physical examination (digital rectal examination) toward more expensive high-tech tools to establish prognosis.

In addition, as a cancer screening test , digital rectal examination is declining in use as other, more effective methods emerge.

Explanations of the most commonly used terms related to prostate cancer can be seen below:

Clinical T Staging Is Still Useful

For their research, investigators identified, in the US National Cancer Database, men with high-risk clinical T2N0M0 prostate cancer treated with radiotherapy and androgen deprivation therapy , in the latter part of the 2000s, a subgroup of 5291 men with or without surgery.

High risk was defined as having any of the following clinical factors at diagnosis: Gleason score> 7, PSA> 20 ng / mL or clinical stage T3a-T4.

As expected, this group also included a proportion of men with cT2 disease determined by physical examination (digital rectal examination). Hall explained that all these men had organ-confined disease but were subclassified by digital rectal examination as cT2a, cT2b and cT2c according to the extent and location of the tumors detected on examination.

At an average follow-up of 5.4 years, the proportion of deaths in each subclass was, for cT2a, % 22.5; for cT2b, % 25.7; and for cT2, % 29.8. Thus, as tumor size detected by digital rectal examination increased, the mortality rate also increased.

In clinical practice, digital rectal examination findings - and the corresponding T subclassification - may influence treatment decisions. For example, for men with high-risk cT2c disease receiving radiation therapy, longer-term hormone suppression may be considered, although the study was not designed to assess this.

In conclusion, there is no reason to move away from digital rectal examination in clinical practice. Overall, it is an inexpensive, historical, practical examination method of prognostic importance whose effectiveness has been tested.

Sources

Jenna F. Borkenhagen ve ark.
Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review.
Journal of the National Comprehensive Cancer Network, July 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Digital Rectal Examination (Rectal Examination with a Finger) Remains an Important Diagnostic Tool for Prostate Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy